COVID-19, SARS and MERS: a neurological perspective
Central to COVID-19 pathophysiology is an acute respiratory infection primarily manifesting
as pneumonia. Two months into the COVID-19 outbreak, however, a retrospective study in …
as pneumonia. Two months into the COVID-19 outbreak, however, a retrospective study in …
<? covid19?> Neurological manifestations and implications of COVID-19 pandemic
G Tsivgoulis, L Palaiodimou… - Therapeutic …, 2020 - journals.sagepub.com
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in
Wuhan, China and rapidly spread worldwide, with a vast majority of confirmed cases …
Wuhan, China and rapidly spread worldwide, with a vast majority of confirmed cases …
Coronavirus 2019 (COVID-19)–associated encephalopathies and cerebrovascular disease: the new orleans experience
T Scullen, J Keen, M Mathkour, AS Dumont, L Kahn - World neurosurgery, 2020 - Elsevier
Background The coronavirus 2019 (COVID-19) pandemic has had a dramatic impact on
health care systems and a variable disease course. Emerging evidence demonstrates that …
health care systems and a variable disease course. Emerging evidence demonstrates that …
[HTML][HTML] COVID-19: an early review of its global impact and considerations for Parkinson's disease patient care
R Bhidayasiri, S Virameteekul, JM Kim… - Journal of movement …, 2020 - ncbi.nlm.nih.gov
While many infectious disorders are unknown to most neurologists, COVID-19 is very
different. It has impacted neurologists and other health care workers, not only in our …
different. It has impacted neurologists and other health care workers, not only in our …
Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic
G Costamagna, E Abati, N Bresolin, GP Comi… - Journal of …, 2021 - Springer
The novel Coronavirus disease-19 (COVID-19) pandemic has posed several challenges for
neuromuscular disorder (NMD) patients. The risk of a severe course of SARS-CoV-2 …
neuromuscular disorder (NMD) patients. The risk of a severe course of SARS-CoV-2 …
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: an international consensus statement
In this consensus statement, we provide updated recommendations on multiple sclerosis
(MS) management during the COVID-19 crisis and the post-pandemic period applicable to …
(MS) management during the COVID-19 crisis and the post-pandemic period applicable to …
Assessing disability and relapses in multiple sclerosis on tele-neurology
M Moccia, R Lanzillo, V Brescia Morra, S Bonavita… - Neurological …, 2020 - Springer
Background As a consequence of the coronavirus disease 2019 (COVID-19) pandemic, a
large amount of consultations will be delivered through tele-medicine, especially for …
large amount of consultations will be delivered through tele-medicine, especially for …
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail
A Bombaci, G Abbadessa, F Trojsi, L Leocani… - Neurological …, 2021 - Springer
Over the last months, due to coronavirus disease (COVID-19) pandemic, containment
measures have led to important social restriction. Healthcare systems have faced a …
measures have led to important social restriction. Healthcare systems have faced a …
Inter-generational effects of technology: Why millennial physicians may be less at risk for burnout than baby boomers
K Nakagawa, P Yellowlees - Current psychiatry reports, 2020 - Springer
Abstract Purpose of Review Younger generations of physicians are using technology more
fluently than previous generations. This has significant implications for healthcare as these …
fluently than previous generations. This has significant implications for healthcare as these …
Impact of COVID-19 on US and Canadian neurologists' therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices
FJ Mateen, S Rezaei, N Alakel, B Gazdag… - Journal of …, 2020 - Springer
Objective To report the understanding and decision-making of neuroimmunologists and their
treatment of patients with multiple sclerosis (MS) during the early stages of the SARS-CoV-2 …
treatment of patients with multiple sclerosis (MS) during the early stages of the SARS-CoV-2 …